InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: SmittyInvestor post# 252

Friday, 05/27/2022 3:13:03 PM

Friday, May 27, 2022 3:13:03 PM

Post# of 278
Please keep in mind that the last agreement that Regnum had with CytoDyn was lead by the former CEO Nader Pourhassan. Not sure if the current BOD are continuing to nurture that relationship/agreement.

Looks like CytoDyn's HIV effort has fizzled out with all HIV study patients put on other therapies and the BLA timeline reevaluated. Other continuing indication research/development (e.g. cancer, NASH, etc) doesn't have any distribution partners lined up that I'm aware of.

What is the Plan B for Regnum if CytoDyn's HIV approvals fall flat on their face?